This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
  • Home
  • /
  • Drugs
  • /
  • D
  • /
  • Doxycycline
  • /
  • Doxycycline DOXYCYCLINE HYCLATE 100 mg/10mL Zydus Lifesciences Limited
FDA Drug information

Doxycycline

Read time: 1 mins
Marketing start date: 27 Apr 2024

Summary of product characteristics


Effective Time

20221105

Version

6

Spl Product Data Elements

Doxycycline Doxycycline DOXYCYCLINE HYCLATE DOXYCYCLINE ANHYDROUS ASCORBIC ACID MANNITOL Doxycycline Doxycycline DOXYCYCLINE HYCLATE DOXYCYCLINE ANHYDROUS ASCORBIC ACID MANNITOL

Application Number

ANDA207757

Brand Name

Doxycycline

Generic Name

Doxycycline

Product Ndc

70771-1121

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – DOXYCYCLINE 100 MG CONTAINER LABEL NDC 70771-1121-1 Doxycycline for Injection, USP 100 mg per vial For Intravenous Infusion MUST DILUTE RECONSTITUTED SOLUTION Single-dose vial Rx only Zydus Pharmaceuticals PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - DOXYCYCLINE 100 MG CARTON LABEL NDC 70771-1121-6 Doxycycline for Injection, USP 100 mg per vial For Intravenous Infusion MUST DILUTE RECONSTITUTED SOLUTION 10 x Single-dose vials Rx only Zydus Pharmaceuticals PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – DOXYCYCLINE 200 MG CONTAINER LABEL NDC 70771-1122-1 Doxycycline for Injection, USP 200 mg per vial For Intravenous Infusion MUST DILUTE RECONSTITUTED SOLUTION Single-dose vial Rx only Zydus Pharmaceuticals PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - DOXYCYCLINE 200 MG CARTON LABEL NDC 70771-1122-1 Doxycycline for Injection, USP 200 mg per vial For Intravenous Infusion MUST DILUTE RECONSTITUTED SOLUTION Single-dose vial Rx only Zydus Pharmaceuticals 100 mg per vial Container Label 100 mg per vial Carton Label 200 mg per vial Container Label 200 mg per vial Carton Label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.